Generation and Validation of a Prognostic Score to Predict Outcome After Re-Irradiation of Recurrent Glioma

Acta Oncologica - United Kingdom
doi 10.3109/0284186x.2012.692882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Hypofractionated Stereotactic Re-Irradiation: Treatment Option in Recurrent Malignant Glioma

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

An Early, Novel Illness Severity Score to Predict Outcome After Cardiac Arrest

Resuscitation
Emergency NursingEmergency MedicineCardiovascular MedicineCardiology
2011English

Letter to Editor Repeated Massive Epistaxis After Re‑irradiation in Recurrent Nasopharyngeal Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2014English

External Validation of a Risk Score to Predict Severe Posthepatectomy Biliary Leakage

HPB
HepatologyGastroenterology
2018English

Development and Validation of a Major Adverse Transplant Event (MATE) Score to Predict Graft Loss After Pediatric Heart Transplantation

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

The Modified Glasgow Prognostic Score in Crohn’s Disease—does It Predict Short-Term Outcome?

European Surgery - Acta Chirurgica Austriaca
Surgery
2018English

Validation of a New Integrated Prognostic Score to Predict Non-Relapse Mortality in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2015English

Development and Validation of a Simple Risk Score to Predict 30-Day Readmission After Percutaneous Coronary Intervention in a Cohort of Medicare Patients

Catheterization and Cardiovascular Interventions
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2016English

Hyperfractionated Re-Irradiation for Recurrent Head and Neck Cancer

Japanese jornal of Head and Neck Cancer
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy